miltirone has been researched along with Cancer of Liver in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kwan, YW; Lee, WY; Or, PM; Wan, DC; Wang, Y; Yeung, JH; Zhou, X | 1 |
1 other study(ies) available for miltirone and Cancer of Liver
Article | Year |
---|---|
Miltirone Is a Dual Inhibitor of P-Glycoprotein and Cell Growth in Doxorubicin-Resistant HepG2 Cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Caspases; Cell Cycle; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Molecular Structure; Phenanthrenes; Salvia miltiorrhiza | 2015 |